(232 days)
Not Found
No
The document mentions "image processing" but does not contain any keywords or descriptions related to AI, ML, deep learning, or neural networks. The performance studies focus on demonstrating equivalence to a predicate device and compliance with IEC standards, without mentioning AI/ML-specific validation metrics or methodologies.
No
The device is used for 2D and 3D imaging, image processing, and display for diagnostic purposes in angiography procedures, not for direct treatment of a disease or condition.
Yes
Explanation: The device is described as processing and displaying images from diagnostic imaging systems and providing "image information and measurement results that are required when performing Angiography procedures." This function supports the diagnostic process by providing visual information and measurements to aid in the assessment of a patient's condition.
No
The device description explicitly states it is a "Workstation" and receives images from "Diagnostic Imaging System and Workstation," implying it is a hardware component or a system that includes hardware, not solely software. It also mentions outputting to "Diagnostic Imaging System, Workstation and/or other PACS devices," further suggesting it is part of a larger hardware-based imaging system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device function: The Angio Workstation (XIDF-AWS801) is an imaging workstation used in conjunction with angiography systems. Its primary function is to process and display medical images obtained from these systems. It provides image information and measurement results for use during angiography procedures.
- No mention of biological samples: The description does not mention the analysis of any biological samples from the human body. The input is described as "images input from Diagnostic Imaging System and Workstation."
Therefore, the device's function is related to medical imaging and image processing, not the analysis of in vitro samples.
N/A
Intended Use / Indications for Use
The Angio Workstation (XIDF-AWS801) is used in combination with an interventional angiography system (Alphenix series systems, Infinix-i series systems and INFX series systems) to provide 2D and 3D imaging of selective catheter angiography procedures for the whole body (includes heart, chest, abdomen, brain and extremity).
When XIDF-AWS801 is combined with Dose Tracking System (DTS), DTS is used with selective catheter angiography procedures for the heart, chest abdomen, pelvis and brain.
Product codes (comma separated list FDA assigned to the subject device)
OWB, JAA
Device Description
The XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.3 is used for images input from Diagnostic Imaging System and Workstation, image processing and display. The processed images can be outputted to Diagnostic Imaging System, Workstation and/or other PACS devices. The XIDF-AWS801 provides the image information and measurement results that are required when performing Angiography procedures.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Interventional angiography system
Anatomical Site
whole body (includes heart, chest, abdomen, brain and extremity), heart, chest, abdomen, pelvis and brain.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
This submission contains test data that demonstrates that the system modifications result in performance that is equal to or better than the predicate system. Testing of the modified system was conducted in accordance with the applicable standards published by the International Electromechanical Commission (IEC) for Medical Devices and XR Systems.
Software Documentation for a Moderate Level of Concern, per the FDA guidance document, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document" issued on May 11, 2005, is also included as part of this submission. Software modules were subject to verification and/or validation testing to ensure that they were properly integrated into the existing software platform. Additionally, the design controls used for this device included risk management and all known risks were mitigated to an acceptable level.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1650 Image-intensified fluoroscopic x-ray system.
(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
September 27, 2022
Canon Medical Systems Corporation % Paul Biggins U.S. Agent/Senior Director Regulatory Affairs Canon Medical Systems USA 2441 Michelle Drive TUSTIN CA 92780
Re: K220342
Trade/Device Name: XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.3 Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: Class II Product Code: OWB, JAA Dated: August 25, 2022 Received: August 29, 2022
Dear Paul Biggins:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Laurel Burk, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K220342
Device Name
XIDF-AWS801, Angio Workstation, (Alphenix Workstation), V9.3
Indications for Use (Describe)
The Angio Workstation (XIDF-AWS801) is used in combination with an interventional angiography system (Alphenix series systems, Infinix-i series systems and INFX series systems) to provide 2D and 3D imaging of selective catheter angiography procedures for the whole body (includes heart, chest, abdomen, brain and extremity).
When XIDF-AWS801 is combined with Dose Tracking System (DTS), DTS is used with selective catheter anglography procedures for the heart, chest abdomen, pelvis and brain.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | |
|---|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K220342 510(k) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of Safe Medical Device Act 1990 and 21 CFR § 807.92
1. CLASSIFICATION and DEVICE NAME
| Classification Name | Solid State X-ray System, Interventional |
|---|---|
| Regulation Number | 21 CFR 892.1650 (Class II) |
| Product Code | OWB, JAA |
| Trade Proprietary Name | XIDF-AWS801, Angio Workstation (Alphenix Workstation) |
| Model Number | XIDF-AWS801, V9.3 |
2. SUBMITTER'S NAME
Canon Medical Systems Corporation 1385 Shimoishigami Otawara-Shi, Tochigi-ken, Japan 324-8550
3. OFFICIAL CORRESPONDENT
Fumiaki Teshima Senior Manager, Quality Assurance Department
4. CONTACT PERSON, U.S. AGENT and ADDRESS
Paul Biggins Sr. Director, Regulatory Affairs Canon Medical Systems USA 2441 Michelle Drive, Tustin, CA 92780 Phone: (714) 669-7808 Fax: (714) 730-1310 pbiggins@us.medical.canon
5. MANUFACTURING SITE
Canon Medical Systems Corporation 1385 Shimoishigami Otawara-shi, Tochigi 324-8550, Japan
6. ESTABLISHMENT REGISTRATION 9614698
-
- DATE PREPARED February 03, 2022
8. TRADE NAME(S) XIDF-AWS801, Angio Workstation, (Alphenix Workstation), V9.3
9. CLASSIFICATION PANEL Radiology
10. DEVICE CLASSIFICATION Class II (per 21 CFR 892.1650)
4
Made For life
11. PRODUCT CODE / DESCRIPTION
Product Code: OWB, JAA
12. PERFORMANCE STANDARD
This device conforms to applicable Performance Standards for Ionizing Radiation Emitting Products [21 CFR Subchapter J, Federal Diagnostic X-ray Equipment Standard].
13. PREDICATE DEVICE
XIDF-AWS801, Angio Workstation (Alphenix Workstation), V8.0 (K181415)
| Product | XIDF-AWS801, Angio Workstation
(Alphenix Workstation), V8.0 | XIDF-AWS801, Angio Workstation,
(Alphenix Workstation), V9.3 |
|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Marketed by | Canon Medical Systems USA | Canon Medical Systems USA |
| Indications For
Use | The Angio Workstation (XIDF-AWS801)
is used in combination with an
interventional angiography system
(Alphenix series systems, Infinix-i
series systems and INFX series
systems) to provide 2D and 3D
imaging of selective catheter
angiography procedures for the whole
body (includes heart, chest, abdomen,
brain and extremity).
When XIDF-AWS801 is combined with
Dose Tracking System (DTS), DTS is
used with selective catheter
angiography procedures for the heart,
chest abdomen, pelvis and brain. | The Angio Workstation (XIDF-AWS801)
is used in combination with an
interventional angiography system
(Alphenix series systems, Infinix-i
series systems and INFX series
systems) to provide 2D and 3D
imaging of selective catheter
angiography procedures for the whole
body (includes heart, chest, abdomen,
brain and extremity).
When XIDF-AWS801 is combined with
Dose Tracking System (DTS), DTS is
used with selective catheter
angiography procedures for the heart,
chest abdomen, pelvis and brain. |
| 510(k) Number | K181415 | K181415 |
| Clearance Date | September 10, 2018 | September 10, 2018 |
14. REASON FOR SUBMISSION
Modification of a cleared device
15. SUBMISSION TYPE
Traditional 510(k)
16. DEVICE DESCRIPTION
The XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.3 is used for images input from Diagnostic Imaging System and Workstation, image processing and display. The processed images can be outputted to Diagnostic Imaging System, Workstation and/or other PACS devices. The XIDF-AWS801 provides the image information and measurement results that are required when performing Angiography procedures.
17. Indications for use
The Angio Workstation (XIDF-AWS801) is used in combination with an interventional angiography system (Alphenix series systems, Infinix-i series systems and INFX series systems) to provide 2D and 3D imaging of selective catheter angiography procedures for the whole body
5
Made For life
(includes heart, chest, abdomen, brain and extremity).
When XIDF-AWS801 is combined with Dose Tracking System (DTS), DTS is used with selective catheter angiography procedures for the heart, chest abdomen, pelvis and brain.
18. SUMMARY OF CHANGE(S)
This submission is to report the following items have been changed:
- . Dynamic Device Stabilization (DDS) software has been improved and new GPU for image processing is included.
- . Windows 10 new OS system is available
- Embolization Planning software has been migrated from the INFX platform ●
- . CAAS Workstation has been updated with vFFR application
- 3D Viewer Software has been updated to include new functions.
- 4D CT improvement was migrated from 4DCT that allows user to superimpose CT image on Angiographic image
- . Needle Guidance was improved which allows up to 5 needles
- Usability improvements are included in this software
19. SAFETY
The device is designed and manufactured under the Quality System Regulations as outlined in 21 CFR § 820 and ISO 13485 Standards. This device is in conformance with the applicable parts of the IEC60601-1 standards. All requirements of the Federal Diagnostic Equipment Standard, as outlined in 21 CFR §1020, that apply to this device, will be met and reported via product report.
LIST OF APPLICABLE STANDARDS
- . IEC60601-1-2:2014
- IEC62304:2006 + A1:2015 .
- IEC62366-1:2015 + A1:2020 ●
- . IEC62368-1:2014
- ISO 14971:2007 ●
20. TESTING
This submission contains test data that demonstrates that the system modifications result in performance that is equal to or better than the predicate system. Testing of the modified system was conducted in accordance with the applicable standards published by the International Electromechanical Commission (IEC) for Medical Devices and XR Systems.
Software Documentation for a Moderate Level of Concern, per the FDA guidance document, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document" issued on May 11, 2005, is also included as part of this submission. Software modules were subject to verification and/or validation testing to ensure that they were properly integrated into the existing software platform. Additionally, the design controls used for this device included risk management and all known risks were mitigated to an acceptable level.
21. SUBSTANTIAL EQUIVALENCE
The XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.3 is substantially equivalent to the XIDF-AWS801, Angio Workstation, V8.0, which received premarket clearance under K181415, marketed by Canon Medical Systems. XIDF-AWS801, Angio Workstation (Alphenix
6
1EDICAL SYSTEMS USA, INC.
Made For life
Workstation), V9.3, includes modifications to the cleared device consisting of software change from V8.0 to V9.3.
The basic system configuration, method of operation, base software and manufacturing process remain unchanged from the cleared device.
22. CONCLUSION
The XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.3 performs in a manner similar to and is intended for the same use as the predicate device, as indicated in product labeling. Based upon this information, conformance to standards, successful completion of software validation, application of risk management and design controls and the performance data presented in this submission it is concluded that the subject device is substantially equivalent in safety and effectiveness to the predicate device.